Tue, Jul 29, 2014, 9:38 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Neurocrine Biosciences Inc. Message Board

  • frogsleapmerlot frogsleapmerlot Jul 20, 2011 9:35 AM Flag

    UC2 P2 results September/October

    UC2 alone if results are positive and NBIX managements is prudant in a partnership deal is worth 2 or 3 points to the current $8 stock price.

    If it gets to market let say in 2016/17 its a $1B/$2B drug.

    frogs

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • frogs

      This time you and I disagree.

      Assuming that you are correct and this is a multi billion dollar revenue producing drug, a partner is going to have to pay just as much to get this and maybe even more so I think your going to be a whole lot light on price if they get one of those $500 million deals with a bundle up front.

      Further this could easily happen at a time when Elagolix enters phaseIII with high expectations.

 
NBIX
13.70+0.52(+3.95%)Jul 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.